GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » UpHealth Inc (OTCPK:UPHL) » Definitions » ROE %

UpHealth (UpHealth) ROE % : -67.26% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is UpHealth ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. UpHealth's annualized net income for the quarter that ended in Dec. 2023 was $-40.1 Mil. UpHealth's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $59.6 Mil. Therefore, UpHealth's annualized ROE % for the quarter that ended in Dec. 2023 was -67.26%.

The historical rank and industry rank for UpHealth's ROE % or its related term are showing as below:

UPHL' s ROE % Range Over the Past 10 Years
Min: -126.5   Med: -88.74   Max: -0.99
Current: -70.41

During the past 4 years, UpHealth's highest ROE % was -0.99%. The lowest was -126.50%. And the median was -88.74%.

UPHL's ROE % is ranked worse than
89.05% of 612 companies
in the Healthcare Providers & Services industry
Industry Median: 4.115 vs UPHL: -70.41

UpHealth ROE % Historical Data

The historical data trend for UpHealth's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UpHealth ROE % Chart

UpHealth Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROE %
-0.99 -126.50 -105.29 -72.19

UpHealth Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -92.80 -31.19 -82.12 -111.18 -67.26

Competitive Comparison of UpHealth's ROE %

For the Health Information Services subindustry, UpHealth's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UpHealth's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, UpHealth's ROE % distribution charts can be found below:

* The bar in red indicates where UpHealth's ROE % falls into.



UpHealth ROE % Calculation

UpHealth's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-57.839/( (105.148+55.104)/ 2 )
=-57.839/80.126
=-72.19 %

UpHealth's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-40.096/( (64.13+55.104)/ 2 )
=-40.096/59.617
=-67.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


UpHealth  (OTCPK:UPHL) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-40.096/59.617
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-40.096 / 69.396)*(69.396 / 233.476)*(233.476 / 59.617)
=Net Margin %*Asset Turnover*Equity Multiplier
=-57.78 %*0.2972*3.9163
=ROA %*Equity Multiplier
=-17.17 %*3.9163
=-67.26 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-40.096/59.617
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-40.096 / -48.436) * (-48.436 / -4.424) * (-4.424 / 69.396) * (69.396 / 233.476) * (233.476 / 59.617)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8278 * 10.9485 * -6.38 % * 0.2972 * 3.9163
=-67.26 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


UpHealth ROE % Related Terms

Thank you for viewing the detailed overview of UpHealth's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


UpHealth (UpHealth) Business Description

Traded in Other Exchanges
N/A
Address
14000 S. Military Trail, Suite 203, Delray Beach, FL, USA, 33484
UpHealth Inc is a digital health company intent on creating a single, integrated platform of technologies and services essential to personalized, affordable, and effective care globally. The company's segment includes Integrated Care Management; Virtual Care Infrastructure; Services and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of revenue from the Americas.
Executives
Avi S Katz director, 10 percent owner, officer: CEO, Pres, Exec Chairman C/O GIGCAPITAL, INC., 3000 EL CAMINO REAL, BLDG 4, SUITE 232, PALO ALTO CA 94306
Jay Walter Jennings officer: Chief Financial Officer C/O EHEALTH, INC., 440 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Mark Guinan director C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Luis Machuca director ITXC CORP, 14600 NW GREENBRIER PARKWAY, BEAVERTON OR 97006
Chirinjeev Kathuria director, 10 percent owner C/O UPHEALTH HOLDINGS, INC., 14000 S. MILITARY TRAIL #203, DELRAY BEACH FL 33484
Mariya Pylypiv director, 10 percent owner 14000 MILITARY TRAIL, #203, DELRAY BEACH FL 33484
Samuel Meckey director, officer: Chief Executive Officer 320 PARK AVENUE, 29TH FL, NEW YORK NY 10022
Samantha Josephine Bray 10 percent owner 2083 WALKER LANE, HOLLADAY UT 84117
Anais Alexandra Bray 10 percent owner 2083, HOLLADAY UT 84117
Jeffery Rex Bray 10 percent owner 2083 WALKER LANE, HOLLADAY UT 84117
Kimberlite Social Infra Private Ltd 10 percent owner IDEAL VILLA VILLA NO 98, KOCH PAKUR, SOUTH 24 PARGANAS K7 700156
Eligere Ltd Liability Co 10 percent owner 9 HAWSER WAY, RANDOLPH NJ 07869
Syed Sabahat Azim 10 percent owner 14000 MILITARY TRAIL, #203, DELRAY BEACH FL 33484
Alexandra Bray 10 percent owner 2083 WALKER LANE, HOLLADAY UT 84117
Anais Bray Protective Irrevocable Trust 10 percent owner 3056 MILLCREEK DELL LANE, SALT LAKE CITY UT 84109